TuisVX1 • ETR
add
Vertex Pharmaceuticals Incorporated
Vorige sluiting
€427,95
Dagwisseling
€432,35 - €437,55
Jaarwisseling
€315,70 - €489,20
Markkapitalisasie
116,14 mjd USD
Gemiddelde volume
141,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,77 mjd | 11,61% |
Bedryfskoste | 371,80 m | 40,94% |
Netto inkomste | 1,05 mjd | 0,98% |
Netto winsgrens | 37,71 | -9,55% |
Wins per aandeel | 4,38 | 7,35% |
EBITDA | 1,18 mjd | 4,56% |
Effektiewe belastingkoers | 14,60% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 6,52 mjd | -45,30% |
Totale bates | 22,24 mjd | 2,37% |
Totale aanspreeklikheid | 6,61 mjd | 26,78% |
Totale ekwiteit | 15,63 mjd | — |
Uitstaande aandele | 257,53 m | — |
Prys om te bespreek | 7,06 | — |
Opbrengs op bates | 13,35% | — |
Opbrengs op kapitaal | 17,09% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,05 mjd | 0,98% |
Kontant van bedrywe | 1,37 mjd | 7,99% |
Kontant van beleggings | -348,00 m | -195,67% |
Kontant van finansiering | -387,50 m | -134,85% |
Netto kontantverandering | 657,10 m | -31,78% |
Beskikbare kontantvloei | 1,09 mjd | 18,41% |
Meer oor
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Gestig
1989
Hoofkwartier
Webwerf
Werknemers
5 400
